- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Alignment Healthcare Announces Secondary Offering
Affiliate of General Atlantic, L.P. to sell 13.2 million shares of Alignment Healthcare common stock
Published on Mar. 2, 2026
Got story updates? Submit your updates here. ›
Alignment Healthcare, Inc., an award-winning Medicare Advantage company, announced the commencement of an underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. The company will not receive any of the proceeds from the sale of the shares.
Why it matters
This secondary offering by an existing investor signals confidence in Alignment Healthcare's growth and performance in the Medicare Advantage market, which has seen increased competition and consolidation in recent years.
The details
The offering is being made pursuant to a shelf registration statement on Form S-3 that has been filed by Alignment Healthcare with the SEC. J.P. Morgan is acting as the underwriter for the proposed offering. The shares will be offered only by means of a prospectus supplement and an accompanying prospectus.
- The shelf registration statement was filed with the SEC and became effective on March 2, 2026.
- The secondary offering is expected to close in the coming weeks.
The players
Alignment Healthcare, Inc.
An award-winning Medicare Advantage company that is championing a new path in senior care.
General Atlantic, L.P.
An affiliate of the private equity firm that is selling 13.2 million shares of Alignment Healthcare common stock.
J.P. Morgan
The investment bank acting as the underwriter for the proposed secondary offering.
What’s next
The secondary offering is expected to close in the coming weeks, pending regulatory approvals and other customary closing conditions.
The takeaway
This secondary offering by an existing investor in Alignment Healthcare signals confidence in the company's growth prospects in the competitive Medicare Advantage market, as it continues to expand its offerings and national footprint.

